These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15049272)

  • 1. [New methods of therapy for ocular inflammatory autoimmune diseases].
    Kubicka-Trzaska A; Undas A
    Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward new therapies for ocular inflammation.
    Rosenbaum JT; Becker MD; Smith JR
    Arch Soc Esp Oftalmol; 2000 Aug; 75(8):511-4. PubMed ID: 11151211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of effective immunotherapy for human autoimmunity.
    Feldmann M; Steinman L
    Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleritis: Immunopathogenesis and molecular basis for therapy.
    Wakefield D; Di Girolamo N; Thurau S; Wildner G; McCluskey P
    Prog Retin Eye Res; 2013 Jul; 35():44-62. PubMed ID: 23454614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic approaches in ocular inflammatory diseases.
    Kurup SK; Chan CC
    Arch Immunol Ther Exp (Warsz); 2005; 53(6):484-96. PubMed ID: 16407781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.
    Durrani K; Zakka FR; Ahmed M; Memon M; Siddique SS; Foster CS
    Surv Ophthalmol; 2011; 56(6):474-510. PubMed ID: 22117884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunology in clinical practice. XIII. Immune diseases of the eye].
    Ooijman FM; van der Lelij A
    Ned Tijdschr Geneeskd; 1998 Feb; 142(9):443-8. PubMed ID: 9562756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The current and future outlook in immunosuppressive therapy for children].
    Goţia S; Ionescu C
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):35-42. PubMed ID: 9524654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
    Theodossiadis PG; Markomichelakis NN; Sfikakis PP
    Retina; 2007; 27(4):399-413. PubMed ID: 17420690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospects of immunotropic therapy of traumatic uveitis].
    Valeeva RG; Grishina VS; Iluridze SL; Isaeva RT
    Vestn Oftalmol; 1998; 114(4):26-8. PubMed ID: 9771084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation.
    Commodaro AG; Bueno V; Belfort R; Rizzo LV
    Autoimmun Rev; 2011 Feb; 10(4):205-9. PubMed ID: 20959149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic prospects in autoimmunity].
    Revillard JP
    Rev Prat; 1994 Jan; 44(1):93-7. PubMed ID: 8178066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune dermatoses: new therapeutic strategies].
    Trüeb RM
    Praxis (Bern 1994); 2000 Sep; 89(37):1460-7. PubMed ID: 11037617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indication and effect of immunosuppression in patients with scleritis].
    Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety.
    Durrani K; Papaliodis GN; Foster CS
    Ophthalmology; 2004 May; 111(5):960-5. PubMed ID: 15121375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.